Decoglurant (RO4995819) is a negative allosteric modulator targeting metabotropic glutamate receptors 2 and 3 (mGluR2/3). It has been investigated preclinically for its antidepressant potential, with studies exploring its effects in both in vitro receptor assays and in vivo behavioral models of depression.